Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takami Sato

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Cancers|February 13, 2026
Cancer Vaccine Targeting Mutated GNAQ-Expressing Uveal MelanomaVitali Alexeev, Mizue Terai, Sergei Koshkin, et al.
American Journal of Ophthalmology|July 21, 2012
Uveal melanoma trapped in the temple of doomCarol L Shields, Arupa Ganguly, Joan O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccineDavid Berd, Takami Sato, Henry C Maguire, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 12, 2008
Role of cytogenetics in management of uveal melanomaJerry A Shields, Carol L Shields, Miguel Materin, et al.
AJR. American Journal of Roentgenology|April 24, 2015
Uveal Melanoma Metastatic to the Liver: Chemoembolization With 1,3-Bis-(2-Chloroethyl)-1-NitrosoureaCarin F Gonsalves, David J Eschelman, Bartley Thornburg, et al.
Melanoma Research|November 2, 2012
A pilot study of sunitinib malate in patients with metastatic uveal melanomaAmit Mahipal, Lukman Tijani, Kathryn Chan, et al.
Retina (Philadelphia, Pa.)|April 25, 2018
CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side EffectsLauren A Dalvin, Carol L Shields, Marlana Orloff, et al.
The Journal of Biological Chemistry|August 9, 2021
Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRsNadia Anikeeva, Sergey Panteleev, Nicholas W Mazzanti, et al.
Current Protocols|April 21, 2021
Orthotopic Human Metastatic Uveal Melanoma Xenograft Mouse Models: Applications for Understanding the Pathophysiology and Therapeutic Management of Metastatic Uveal MelanomaMizue Terai, Ken Kageyama, Takahito Sugase, et al.
Immunologic Research|December 6, 2011
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapyTakami Sato, Mizue Terai, Yutaka Tamura, et al.
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Cancers|February 13, 2026
Cancer Vaccine Targeting Mutated GNAQ-Expressing Uveal MelanomaVitali Alexeev, Mizue Terai, Sergei Koshkin, et al.
American Journal of Ophthalmology|July 21, 2012
Uveal melanoma trapped in the temple of doomCarol L Shields, Arupa Ganguly, Joan O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccineDavid Berd, Takami Sato, Henry C Maguire, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 12, 2008
Role of cytogenetics in management of uveal melanomaJerry A Shields, Carol L Shields, Miguel Materin, et al.
AJR. American Journal of Roentgenology|April 24, 2015
Uveal Melanoma Metastatic to the Liver: Chemoembolization With 1,3-Bis-(2-Chloroethyl)-1-NitrosoureaCarin F Gonsalves, David J Eschelman, Bartley Thornburg, et al.
Melanoma Research|November 2, 2012
A pilot study of sunitinib malate in patients with metastatic uveal melanomaAmit Mahipal, Lukman Tijani, Kathryn Chan, et al.
Retina (Philadelphia, Pa.)|April 25, 2018
CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side EffectsLauren A Dalvin, Carol L Shields, Marlana Orloff, et al.
The Journal of Biological Chemistry|August 9, 2021
Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRsNadia Anikeeva, Sergey Panteleev, Nicholas W Mazzanti, et al.
Current Protocols|April 21, 2021
Orthotopic Human Metastatic Uveal Melanoma Xenograft Mouse Models: Applications for Understanding the Pathophysiology and Therapeutic Management of Metastatic Uveal MelanomaMizue Terai, Ken Kageyama, Takahito Sugase, et al.
Immunologic Research|December 6, 2011
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapyTakami Sato, Mizue Terai, Yutaka Tamura, et al.
Pageof 12